Hyperglycemia at admission and during hospital stay are independent risk factors for mortality in high risk cardiac patients admitted to an intensive cardiac care unit

European Heart Journal: Acute Cardiovascular Care

Volumn 2, Issue 4, 2013, Pages 306-313

  Lipton, Ja ^a   Barendse, Rj ^a   Van Domburg, Rt ^a   Schinkel, Afl ^a   Boersma, H ^a   Simoons, Ml ^a   Akkerhuis, Km ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

acute coronary syndrome; Glucose levels; intensive cardiac care; prognosis

Indexed keywords

ACUTE CORONARY SYNDROME; GLUCOSE LEVELS; INTENSIVE CARDIAC CARE; PROGNOSIS;

ACUTE CORONARY SYNDROME; AGED; BLOOD GLUCOSE; CORONARY CARE UNITS; FEMALE; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TERTIARY CARE CENTERS;

EID: 84901608689     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872613489304     Document Type: Article

References (22)

1. Penfold S, Gouni R, Hamilton P, et al. Immediate in-patient management of hyperglycaemia–confusion rather than consensus?” QJM 2008; 101: 87–90.
2. Weston C, Walker L Birkhead J. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome. Heart 2007; 93: 1542–1546.
3. Le Floch JP, Escuyer P, Baudin E, et al. Blood glucose area under the curve. Methodological aspects. Diabetes Care 1990; 13: 172–175.
4. Lipton JA, Barendse RJ, Akkerhuis KM, et al. Evaluation of a clinical decision support system for glucose control: Impact of protocol modifications on compliance and achievement of glycemic targets. Crit Pathw Cardiol 2010; 9: 140–175.
5. Asadollahi K, Beeching N and Gill G. Hyperglycaemia and mortality. J R Soc Med 2007; 100: 503–507.
6. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: Implications for patients with and without recognized diabetes. Circulation 2005; 111: 3078–3086.
7. Rydén L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007; 28: 88–136.
8. Junger A, Böttger S, Engel J, et al. Automatic calculation of a modified APACHE II score using a patient data management system (PDMS). Int J Med Inform 2002; 65: 145–157.
9. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study. Lancet 2002; 359: 2140–2144.
10. Beck JA, Meisinger C, Heier M, et al. Effect of blood glucose concentrations on admission in non-diabetic versus diabetic patients with first acute myocardial infarction on short- and long-term mortality (from the MONICA/KORA Augsburg Myocardial Infarction Registry). Am J Cardiol 2009; 104: 1607–1612.
11. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355: 773–778.
12. Tansey MJ and Opie LH. Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction. Lancet 1983; 2: 419–422.
13. Oliver MF. Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes. Am J Med 2002; 112: 305–311.
14. Suleiman M, Hammerman H, Boulos M, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: A prospective study. Circulation. 2005; 111: 754–760.
15. Aronson D, Hammerman H, Suleiman M, et al. Usefulness of changes in fasting glucose during hospitalization to predict long-term mortality in patients with acute myocardial infarction. Am J Cardiol 2009; 104: 1013–1017.
16. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359–1367.
17. Malmberg K, Norhammar A, Wedel H, et al. Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction. Long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation 1999; 99: 2626–2632.
18. Malmberg K, Rydén L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): Effects on mortality and morbidity. Eur Heart J 2005; 26: 650–661.
19. NICE-SUGAR study investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283–1297.
20. Lipton JA, Barendse RJ, Schinkel AFL, et al. Impact of an alerting clinical decision support system for glucose control on protocol compliance and glycemic control in the intensive cardiac care unit. Diabetes Technol Ther 2011; 13: 343–349.
21. Wahab NN, Cowden EA, Pearce NJ, et al; ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40: 1748–1754.
22. De Mulder M, Cornel JH, van der Ploeg T, et al. Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy. Am Heart J 2010; 160: 412–419.